John B. Henneman III - May 18, 2021 Form 4 Insider Report for Anika Therapeutics, Inc. (ANIK)

Role: Director
Signature: /s/ John B. Henneman, III
Stock symbol: ANIK
Transactions as of: May 18, 2021
Transactions value $: $85,720
Form type: 4
Date filed: 5/20/2021, 04:39 PM
Next filing: May 24, 2021

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ANIK	Common Stock	Purchase	$85.7K	+2K	+21.48%	$42.86	11.3K	May 18, 2021	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	On May 18, 2021, Mr. Henneman purchased 2,000 shares in multiple trades ranging from $42.63 to $42.98. The price reported above reflects the weighted average purchase price. Mr. Henneman undertakes to provide the Securities and Exchange Commission staff, the issuer, or any security holder, upon request, full information regarding the number of shares and prices at which the transactions were effected.

Content

On May 18, 2021, Mr. Henneman purchased 2,000 shares in multiple trades ranging from $42.63 to $42.98. The price reported above reflects the weighted average purchase price. Mr. Henneman undertakes to provide the Securities and Exchange Commission staff, the issuer, or any security holder, upon request, full information regarding the number of shares and prices at which the transactions were effected.